Iradimed Co (IRMD) Stock Analysis

Iradimed Co (IRMD) is a publicly traded company in the HEALTHCARE sector. It trades at $89.86, carries a market capitalization of $1.18B, a price-to-earnings ratio of 50.30. This page summarizes the public market data, fundamentals, and frequently asked questions for IRMD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $89.86
• Market Cap: $1.18B
• P/E Ratio: 50.30
• EPS: $1.83
• 52-Week High: $107.44
• 52-Week Low: $54.35

Market Sentiment

Iradimed Co currently has a Neutral sentiment score of 0.04.

About Iradimed Co

Iradimed Corporation is a leading developer and manufacturer of MRI-compatible medical devices, strategically headquartered in Winter Springs, Florida. With a focus on innovative solutions that significantly improve patient care during magnetic resonance imaging, the company serves both domestic and international markets. Iradimed's dedication to advancing medical technology and its specialized product offerings position it as a compelling investment opportunity for institutional investors lo...

GNG Research Analysis

GNG Research scores Iradimed Co (IRMD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IRMD.

Frequently Asked Questions

Does IRMD pay dividends?

Iradimed Co (IRMD) does not currently pay a regular dividend.

What is IRMD's P/E ratio?

Iradimed Co has a price-to-earnings (P/E) ratio of 50.30.

What is IRMD's market cap?

Iradimed Co (IRMD) has a market capitalization of $1.18B with a current stock price of $89.86.